AngioDynamics, Navistar, Talbots, UDR, ZymoGenetics: U.S. Equity Preview

Shares of the following companies may have unusual moves in U.S. trading. Stock symbols are in parentheses, and prices are as of 7:50 a.m. in New York unless noted otherwise.

Standard & Poor’s 500 Index futures expiring in September rose 0.3 percent to 1094.20.

Altera Corp. (ALTR US) gained 3.6 percent to $27.58. The maker of programmable semiconductors boosted its third-quarter revenue forecast, predicting growth of as much as 14 percent from the previous three months. The company had earlier anticipated an increase of 8 percent at most.

AngioDynamics Inc. (ANGO US) dropped 4.8 percent to $14.50 in trading after exchanges closed yesterday. The maker of devices to treat cancer and heart disease said in a preliminary statement that it earned 8 cents a share at most in the fiscal first quarter. Analysts, on average, estimated profit of 11 cents, according to a Bloomberg survey.

Navistar International Inc. (NAV US): The maker of commercial and military vehicles reported third-quarter revenue that fell short of the average analyst estimate in a Bloomberg survey and lowered its full-year revenue forecast.

Phillips-Van Heusen Corp. (PVH US) rose 2 percent to $51.51. The clothing maker increased its full-year forecast, saying it expects to earn as much as $3.80 a share excluding some items. The company had previously projected $3.65 at most.

RTI Biologics Inc. (RTIX US): The specialist in tissue implants reduced its annual earnings forecast to 12 cents a share at most, down from a previous estimate of at least 15 cents.

Talbots Inc. (TLB US) fell 10 percent to $10. The women’s clothing retailer forecast third-quarter profit excluding some items of 22 cents to 28 cents a share, compared with an average analyst estimate of 30 cents in a Bloomberg survey.

UDR Inc. (UDR US) slipped 4 percent to $20.65. The apartment real estate investment trust said it will buy five operating communities and one pre-sale venture for $455.1 million.

Wet Seal Inc. (WTSLA US) climbed 5.3 percent to $3.36 in after-hours trading yesterday. The apparel chain for teenage girls said it plans to buy back as much as $25 million of shares.

ZymoGenetics Inc. (ZGEN US) surged 84 percent to $9.74. The Seattle-based developer of treatments for cancer and autoimmune diseases agreed to be bought by Bristol-Myers Squibb Co. (BMY US) for $9.75 a share, or $885 million.

To contact the reporter on this story: Elizabeth Stanton in New York at estanton@bloomberg.net